SecBot SecBot
SECBOTREPLAY Home › Report › BVS

BVS · Bioventus reported strong Q4 2025 results with $157.9M revenue (2.8%…

Bioventus Inc. · 8-K filed Mar 5, 2026 at 07:35 ET

At the news

BULLISHIMPACT 8/10

8-K filed Mar 5, 2026 at 07:35 ET

Bioventus reported strong Q4 2025 results with $157.9M revenue (2.8% YoY growth, 10% organic growth) and GAAP EPS of $0.21, reversing a prior-year loss. The company achieved $38M in operating cash flow (97% increase) and issued 2026 guidance projecting $600-610M revenue and $0.73-0.77 Adjusted EPS, indicating continued growth momentum.

  • Q4 revenue: $157.9M (+2.8% YoY, +10% organic)
  • Q4 GAAP EPS: $0.21 (vs. $0.00 prior year)
  • Q4 cash from operations: $38M (+97% YoY)
  • 2026 guidance: $600-610M revenue (+6-7%), $0.73-0.77 Adjusted EPS (+7-13%)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access